AwardTape · Defense awards · Research and development · Defense systems R&D · W911QY20C0114
W911QY20C0114: $0 definitive contract to Pathovacs Inc
Pathovacs Inc holds a definitive contract from Department of the Army with $0 obligated since Oct 2023 and $976K obligated over its life, against a ceiling of $976K. Latest action Mar 13, 2024.
Sttr phase ii
| PIID | W911QY20C0114 |
|---|---|
| Type | definitive contract |
| Company | Pathovacs Inc |
| Agency | Department of the Army |
| Contracting office | W6QK ACC-APG |
| Category | Research and development · Defense systems R&D |
| PSC | AD25 R&D- DEFENSE OTHER: SERVICES (OPERATIONAL SYSTEMS DEVELOPMENT) |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $976K |
| Ceiling (base and all options) | $976K |
| Base date | Sep 1, 2020 |
| Latest action | Mar 13, 2024 |
| End date | May 29, 2023 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | IA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial